ClinicalTrialsFinder

Refractory Hairy Cell Leukemia Clinical Trials in Columbus, Ohio

1 recruitingColumbus, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

Hairy Cell LeukemiaRecurrent Hairy Cell LeukemiaRefractory Hairy Cell Leukemia
National Cancer Institute (NCI)84 enrolled4 locationsNCT06965114